AstraZeneca plc (NYSE:AZN)‘s stock had its “neutral” rating restated by Zacks in a research report issued to clients and investors on Friday. They currently have a $79.00 price target on the stock. Zacks‘s price objective suggests a potential upside of 6.18% from the stock’s previous close. AstraZeneca plc (ADR) (NYSE:AZN) shares moved down -0.04% in last trading session and was closed at $74.10, while trading in range of $74.07 – $74.52. AstraZeneca plc (ADR) (NYSE:AZN) year to date (YTD) performance is 28.40%.
Sanofi SA (NYSE:SNY)‘s stock had its “neutral” rating reiterated by Zacks in a report issued on Friday. They currently have a $57.00 price target on the stock. Zacks‘s price objective points to a potential upside of 4.88% from the company’s current price. Sanofi SA (ADR) (NYSE:SNY) net profit margin is 9.10% and weekly performance is -2.00%. On last trading day company shares ended up $53.31. Analysts mean target price for the company is $57.88. Sanofi SA (ADR) (NYSE:SNY) distance from 50-day simple moving average (SMA50) is 0.95%.
On June 20, Novartis AG (ADR) (NYSE:NVS)’s offices in Italy were searched by authorities seeking information on the pricing of two influenza vaccines, adding to the Swiss drugmaker’s woes in the country. Novartis AG (ADR) (NYSE:NVS) shares advanced 0.21% in last trading session and ended the day on $90.38. NVS Gross Margin is 66.50% and its return on assets is 7.80%. Novartis AG (ADR) (NYSE:NVS) quarterly performance is 11.07%.
On June 26, 2014, Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, and actress S. Epatha Merkerson are bringing the America’s Diabetes Challenge: Get to Your Goals program to Washington, D.C. to encourage African Americans with type 2 diabetes to know their A1C — their average blood sugar level over the past two to three months — and talk to their doctors about setting and attaining a personal A1C goal. Merkerson, one of the 4.9 million African-American adults living with type 2 diabetes, will attend the American Diabetes Association’s Live Empowered event in Washington, D.C. at the Kreeger Theater at Arena Stage on June 26 to share her story. Merck & Co., Inc. (NYSE:MRK) shares moved down -1.71% in last trading session and was closed at $57.53, while trading in range of $57.47 – $58.52. Merck & Co., Inc. (NYSE:MRK) year to date (YTD) performance is 16.72%.
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) shares moved up 1.20% in last trading session and was closed at $37.09, while trading in range of $36.88 – 37.10.